NovaBay Pharmaceuticals, Inc. (NBY)

NYSEAMERICAN: NBY · Real-Time Price · USD

Compare

4.750

+0.180 (3.94%)

At close: Dec 24, 2025, 1:00 PM EST

4.820

+0.070 (1.47%)

After-hours: Dec 24, 2025, 5:00 PM EST

NovaBay Pharmaceuticals Market Cap

NovaBay Pharmaceuticals has a market cap or net worth of $598.55 million as of December 24, 2025. Its market cap has increased by 20,539.69% in one year.

Market Cap

598.55M

Enterprise Value

597.21M

1-Year Change

20,539.69%

Ranking

#2925

Market Cap Chart

Since October 26, 2007, NovaBay Pharmaceuticals's market cap has increased from $76.50M to $598.55M, an increase of 682.42%. That is a compound annual growth rate of 11.98%.

Market Cap History

Date	Market Cap	% Change
Dec 24, 2025	598.60M	20,541.38%
Dec 31, 2024	2.90M	123.08%
Dec 29, 2023	1.30M	-63.89%
Dec 30, 2022	3.60M	-78.70%
Dec 31, 2021	16.90M	-41.92%
Dec 31, 2020	29.10M	62.57%
Dec 31, 2019	17.90M	35.61%
Dec 31, 2018	13.20M	-77.70%
Dec 29, 2017	59.20M	18.64%
Dec 30, 2016	49.90M	612.86%
Dec 31, 2015	7.00M	-78.46%
Dec 31, 2014	32.50M	-32.85%
Dec 31, 2013	48.40M	43.62%
Dec 31, 2012	33.70M	-11.32%
Dec 30, 2011	38.00M	-1.81%
Dec 31, 2010	38.70M	-19.21%
Dec 31, 2009	47.90M	118.72%
Dec 31, 2008	21.90M	-72.59%
Dec 31, 2007	79.90M	4.44%
Oct 26, 2007	76.50M	-

View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	959.53B
Johnson & Johnson	495.78B
AbbVie	404.36B
UnitedHealth Group	294.22B
AstraZeneca	287.19B
Novartis AG	267.64B
Merck & Co.	260.71B
Novo Nordisk	232.28B

Market Cap Rankings